Confetti-like hypopigmentation: a rare complication of common phototherapeutic modalityEditor Hypopigmentation and vitiligo occurring during psoralen and ultraviolet A (PUVA) therapy have been described in the literature. 1,2 Leucoderma punctatum, a confetti-like hypopigmentation, as a distinct entity was first described by Falabela et al. 3 A 21-year-old woman presented with multiple asymptomatic, punctiform, achromic spots of 1-month duration, distributed predominantly on extensor aspect of extremities. She had vitiligo vulgaris and was being treated with trimethylpsoralen 0.6 mg/kg, three times per week, followed by UVA exposure for 3 months before appearance of these lesions. Before starting PUVA treatment she was given 8 months' treatment of narrowband ultraviolet B (NBUVB), during which no similar lesion was observed. She was shifted to PUVA as there was minimal improvement of vitiligo with NBUVB. She had skin type V and had 40% repigmentation of the vitiliginous lesions over this period. Her disease was stable during therapy. On examination she had several small hypopigmented to depigmented macules, round to oval in shape, with well-defined margins and measuring about 1.5 mm, which were distributed over the repigmented areas ( fig. 1). These lesions were distributed over extensor aspect of the extremities and were predominantly perifollicular. There was no history of phototoxic reaction or inflammatory lesions. Skin biopsy was taken from a representative lesion, which showed patchy loss of pigment in basal keratinocytes with mild hyperkeratosis of the epidermis. The photochemotherapy was subsequently discontinued.Falabela et al. 3 first described leucoderma punctatum in 1988, in 13 vitiligo patients during and after PUVASOL (oral psoralen followed by solar UV exposure) treatment as leucoderma distinct from idiopathic guttate hypomelanosis and vitiligo. Later, Park et al. 4 reported four cases of generalized punctate leucoderma after UVB phototherapy for psoriasis. Most of the cases were females. Dogra et al. 5 first reported a case of leucoderma punctatum appearing after systemic PUVA therapy. Recently, it has been reported after topical PUVA treatment for segmental vitiligo by Park et al. 6 The typical skin lesions described are multiple discrete well-defined macules of size varying from 0.5 to 1.5 mm, most commonly located on the upper and lower extremities. Special stains for melanocytes show a decreased number of functional melanocytes. In ultrastructural study by Falabella et al., 3 cellular damage within keratinocytes and melanocytes was evident in form of intracellular oedema and intracytoplasmic vacuolar degeneration. Although pathogenesis is not well understood, the most likely cause is PUVA and UVB phototoxiciy-induced damage to melanocytes. Park et al. 4 also suggested that cumulative UVB phototoxicity may be the cause of leucoderma punctatum. In this case, perhaps the exposure to both NBUVB and PUVA was the cause of phototoxicity and appearance of these lesions. It is important to be aware o...